Myriad Genetics, Inc.
MYGN
$4.81
-$0.34-6.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 149.60M | 145.40M | 74.40M | 91.80M | 102.40M |
| Total Receivables | 115.30M | 118.00M | 137.00M | 120.40M | 121.20M |
| Inventory | 30.60M | 31.60M | 28.70M | 28.30M | 27.50M |
| Prepaid Expenses | 35.40M | 49.80M | 44.20M | 46.70M | 37.40M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.70M | -- | -- | -- | 9.50M |
| Total Current Assets | 332.60M | 344.80M | 284.30M | 287.20M | 298.00M |
|
|
|||||
| Total Current Assets | 332.60M | 344.80M | 284.30M | 287.20M | 298.00M |
| Net Property, Plant & Equipment | 163.40M | 162.00M | 164.20M | 167.40M | 172.40M |
| Long-term Investments | 51.60M | 51.60M | 51.60M | 286.30M | 286.30M |
| Goodwill | 51.60M | 51.60M | 51.60M | 286.30M | 286.30M |
| Total Other Intangibles | 153.40M | 163.10M | 170.10M | 257.50M | 262.40M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.60M | 6.60M | 7.10M | 7.70M | 8.50M |
| Total Assets | 706.60M | 728.10M | 677.30M | 1.01B | 1.03B |
|
|
|||||
| Total Accounts Payable | 30.00M | 31.80M | 30.90M | 28.10M | 32.30M |
| Total Accrued Expenses | 71.30M | 77.20M | 70.00M | 76.70M | 86.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.90M | 7.90M | 68.40M | 10.90M | 12.80M |
| Total Finance Division Other Current Liabilities | 25.60M | 31.10M | 30.60M | 35.40M | 32.50M |
| Total Other Current Liabilities | 25.60M | 31.10M | 30.60M | 35.40M | 32.50M |
| Total Current Liabilities | 133.80M | 148.00M | 199.90M | 151.10M | 164.10M |
|
|
|||||
| Total Current Liabilities | 133.80M | 148.00M | 199.90M | 151.10M | 164.10M |
| Long-Term Debt | 119.90M | 119.50M | -- | 59.30M | 39.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 83.00M | 84.90M | 86.20M | 87.40M | 87.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.90M | 2.90M | 3.10M | 3.40M | 34.90M |
| Total Liabilities | 338.60M | 355.30M | 289.20M | 301.20M | 326.50M |
|
|
|||||
| Common Stock & APIC | 1.49B | 1.49B | 1.48B | 1.46B | 1.46B |
| Retained Earnings | -1.12B | -1.11B | -1.09B | -756.90M | -756.80M |
| Treasury Stock & Other | 800.00K | -100.00K | -100.00K | -600.00K | -800.00K |
| Total Common Equity | 368.00M | 372.80M | 388.10M | 704.90M | 701.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 368.00M | 372.80M | 388.10M | 704.90M | 701.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 368.00M | 372.80M | 388.10M | 704.90M | 701.10M |
|
|
|||||